Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hasan Selim, Güler"'
Autor:
Ümit Karaoğullarından, Yüksel Gümürdülü, Oğuz Üsküdar, Emre Odabaş, Hasan Selim Güler, Cansu Geçkalan, Burcu Aslan Benli, Anıl Delik, Asena Ayça Özdemir, Sedef Kuran
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 35, Iss 3, Pp 204-211 (2024)
Background/Aims: Hepatocellular carcinoma is a major cause of mortality and morbidity in both cirrhotic and non-cirrhotic patients, and most patients are suitable for locoregional and/or systemic therapy at the time of diagnosis. In this study, we ai
Externí odkaz:
https://doaj.org/article/8ab6a9be41344fd595e287bb50f622d7
Autor:
Hasan Selim Güler, Oğuz Üsküdar
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 35, Iss 3, Pp 262-263 (2024)
Externí odkaz:
https://doaj.org/article/d7c670b36bae460d92905203e0b35676
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Nur, Tozluklu, Emine, Bağir, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 35:89-93
Hepatocellular carcinoma (HCC) is the seventh most common cancer all worldwide and is second in cancer-related deaths. In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as well as early diagn
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58793476e9943a77636d3c9f1df7e4a1
https://doi.org/10.1097/meg.0000000000002452
https://doi.org/10.1097/meg.0000000000002452
Autor:
Ümit, Karaoğullarindan, Yüksel, Gümürdülü, Oguz, Üsküdar, Emre, Odabaş, Hasan Selim, Güler, Anil, Delik, Sedef, Kuran
Publikováno v:
European Journal of Gastroenterology & Hepatology. 34:956-960
Hepatocellular carcinoma (HCC) is a cancer with a poor prognosis, its incidence increases with age. The risk of developing HCC is highest in the seventh decade. In this study, we aimed to determine the clinicopathological differences, treatment choic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48d6c9eb636530ebb1571d07c01b29f0
https://doi.org/10.1097/meg.0000000000002396
https://doi.org/10.1097/meg.0000000000002396
Autor:
Ayşe Bahar Keleşoğlu Dinçer, Müçteba Enes Yayla, Tahsin Murat Turgay, Serdar Sezer, Dilara Dönmez Güler, Aşkın Ateş, Didem Sahin Eroglu, Gülay Kinikli, Emine Gözde Aydemir Gülöksüz, Hasan Selim Güler, Murat Torgutalp, Zeynep Ceren Karahan, İlyas Ercan Okatan, Mehmet Levent Yüksel
Publikováno v:
TURKISH JOURNAL OF MEDICAL SCIENCES. 51:2690-2697
AIM High Mobility Group Box-1 (HMGB-1) is a nuclear protein acting as a proinflammatory molecule. The serum HMGB-1 levels were found elevated in chronic inflammatory diseases. In this cross-sectional study, serum HMGB-1 levels in Behcet's disease (BD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74156ce7ac10679fb711d2b5002c8821
https://doi.org/10.3906/sag-2101-116
https://doi.org/10.3906/sag-2101-116
Autor:
Ümit Karaogullarindan, Oguz Uskudar, Emre Odabas, Nur Tozluklu, Hasan Selim Güler, Sedef Kuran, Burcu Arslan Benli, Yüksel Gümürdülü
Purpose: Hepatocellular carcinoma (HCC) is the seventh most common cancer all over the world and is second in cancer-related deaths. . In HCC, whose prognosis is still not good despite current treatments, there is a need for prognostic markers as wel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb4988ae97c9a44030274ed4b4817c51
https://doi.org/10.21203/rs.3.rs-1375407/v1
https://doi.org/10.21203/rs.3.rs-1375407/v1
Autor:
Dilara Dönmez, Güler, Ayşe Bahar, Keleşoğlu Dinçer, Zeynep Ceren, Karahan, Hasan Selim, Güler, Müçteba Enes, Yayla, Serdar, Sezer, Emine Gözde, Aydemir Gülöksüz, İlyas Ercan, Okatan, Murat, Torgutalp, Didem Şahin, Eroğlu, Mehmet Levent, Yüksel, Tahsin Murat, Turgay, Gülay, Kınıklı, Aşkın, Ateş
Publikováno v:
Turkish Journal of Medical Sciences
Background/aim High mobility group box- 1 (HMGB- 1) is a nuclear protein acting as a proinflammatory molecule. The serum HMGB- 1 levels were found elevated in chronic inflammatory diseases. In this cross-sectional study, serum HMGB- 1 levels in Behce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8e90b256295ddc09f93760e0d09ced2b
https://pubmed.ncbi.nlm.nih.gov/34333900
https://pubmed.ncbi.nlm.nih.gov/34333900